4UY1
Novel pyrazole series of group X Secretory Phospholipase A2 (sPLA2-X) inhibitors
Summary for 4UY1
Entry DOI | 10.2210/pdb4uy1/pdb |
Descriptor | GROUP 10 SECRETORY PHOSPHOLIPASE A2, CALCIUM ION, PENTAETHYLENE GLYCOL, ... (7 entities in total) |
Functional Keywords | hydrolase, fragment based lead generation, virtual screening, drug discovery |
Biological source | HOMO SAPIENS (HUMAN) |
Cellular location | Secreted : O15496 |
Total number of polymer chains | 2 |
Total formula weight | 31274.07 |
Authors | Sandmark, J.,Oster, L.,Hallberg, K.,Bodin, C.,Chen, H. (deposition date: 2014-08-28, release date: 2014-10-15, Last modification date: 2018-04-04) |
Primary citation | Chen, H.,Knerr, L.,Akerud, T.,Hallberg, K.,Bodin, C.,Oster, L.,Rohman, M.,Osterlund, K.,Beisel, H.G.,Olsson, T.,Brengdhal, J.,Sandmark, J. Discovery of a Novel Pyrazole Series of Group X Secreted Phospholipase A2 Inhibitor (Spla2X) Via Fragment Based Virtual Screening Bioorg.Med.Chem.Lett., 24:5251-, 2014 Cited by PubMed: 25316315DOI: 10.1016/J.BMCL.2014.09.058 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report